Literature DB >> 9241705

Antithrombin and its inherited deficiency states.

H H van Boven1, D A Lane.   

Abstract

Antithrombin is the primary inhibitor of thrombin that also inhibits many of the other activated serine proteinases involved in blood coagulation. A hypercoagulable state occurs when a deficiency of antithrombin exists in plasma; the deficiency may be either inherited or acquired. This failure to regulate adequately the activity of coagulation proteinases can, with additional provocation, result in clot formation and in the clinical presentation of thromboembolic disease. The structure and function of antithrombin, nature and heterogeneity of the molecular defects in the antithrombin gene associated with inherited antithrombin deficiency, prevalence and the natural history of inherited antithrombin deficiency are all reviewed here.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9241705

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  26 in total

1.  The Laboratory of Hypercoagulability: A Review of Present-Day Techniques.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-07       Impact factor: 2.300

Review 2.  Heparan sulfate: antithrombotic or not?

Authors:  Jeffrey I Weitz
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

3.  Normal levels of anticoagulant heparan sulfate are not essential for normal hemostasis.

Authors:  Sassan HajMohammadi; Keiichi Enjyoji; Marc Princivalle; Patricia Christi; Miroslav Lech; David Beeler; Helen Rayburn; John J Schwartz; Samad Barzegar; Ariane I de Agostini; Mark J Post; Robert D Rosenberg; Nicholas W Shworak
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

Review 4.  Inhibitory serpins. New insights into their folding, polymerization, regulation and clearance.

Authors:  Peter G W Gettins; Steven T Olson
Journal:  Biochem J       Date:  2016-08-01       Impact factor: 3.857

5.  A Mathematical Model of Venous Thrombosis Initiation.

Authors:  Priscilla Elizondo; Aaron L Fogelson
Journal:  Biophys J       Date:  2016-12-20       Impact factor: 4.033

Review 6.  Molecular mechanisms of antithrombin-heparin regulation of blood clotting proteinases. A paradigm for understanding proteinase regulation by serpin family protein proteinase inhibitors.

Authors:  Steven T Olson; Benjamin Richard; Gonzalo Izaguirre; Sophia Schedin-Weiss; Peter G W Gettins
Journal:  Biochimie       Date:  2010-06-02       Impact factor: 4.079

7.  Conformational activation of antithrombin by heparin involves an altered exosite interaction with protease.

Authors:  Gonzalo Izaguirre; Sonia Aguila; Lixin Qi; Richard Swanson; Ryan Roth; Alireza R Rezaie; Peter G W Gettins; Steven T Olson
Journal:  J Biol Chem       Date:  2014-10-20       Impact factor: 5.157

Review 8.  Mice deficient in heparan sulfate 3-O-sulfotransferase-1: normal hemostasis with unexpected perinatal phenotypes.

Authors:  Nicholas W Shworak; Sassan HajMohammadi; Ariane I de Agostini; Robert D Rosenberg
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

9.  The critical role of hinge-region expulsion in the induced-fit heparin binding mechanism of antithrombin.

Authors:  Jonathan Langdown; Klara J Belzar; Wendy J Savory; Trevor P Baglin; James A Huntington
Journal:  J Mol Biol       Date:  2009-03-13       Impact factor: 5.469

Review 10.  Empirical and theoretical phenotypic discrimination.

Authors:  K E Brummel-Ziedins; T Orfeo; F R Rosendaal; A Undas; G E Rivard; S Butenas; K G Mann
Journal:  J Thromb Haemost       Date:  2009-07       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.